Cases & Deals

  • Home
  • Practices
  • Société Générale, Kempen, and Trout Capital complete €29.9 million private placement of new and secondary shares by DBV Technologies

Share

Société Générale, Kempen, and Trout Capital complete €29.9 million private placement of new and secondary shares by DBV Technologies

November 2013

Client(s) Société Générale SA, Kempen & Co., and Trout Capital

Jones Day represented Société Générale, Kempen & Co., and Trout Capital in connection with a €29.9 million (US$40.1 million) private placement of new and secondary shares by DBV Technologies, a biotech company specializing in food allergy with innovative products for diagnosis and treatment.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.